Guardian Wealth Advisors (North Carolina)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Sell
4,589
-268
-6% -$15.6K 0.02% 293
2025
Q4
$262K Buy
+4,857
New +$234K 0.02% 312
2025
Q3
Sell
-5,761
Closed -$267K 362
2025
Q2
$267K Buy
5,761
+275
+5% +$13.5K 0.02% 284
2025
Q1
$335K Buy
5,486
+288
+6% +$16.8K 0.03% 236
2024
Q4
$294K Buy
5,198
+946
+22% +$52.9K 0.02% 253
2024
Q3
$220K Sell
4,252
-1,577
-27% -$74K 0.02% 255
2024
Q2
$242K Sell
5,829
-1,209
-17% -$54.1K 0.03% 232
2024
Q1
$382K Buy
7,038
+661
+10% +$33.7K 0.05% 187
2023
Q4
$327K Sell
6,377
-615
-9% -$32.3K 0.05% 184
2023
Q3
$406K Sell
6,992
-699
-9% -$42.8K 0.07% 144
2023
Q2
$492K Buy
7,691
+329
+4% +$22.1K 0.08% 126
2023
Q1
$510K Sell
7,362
-83
-1% -$5.85K 0.09% 114
2022
Q4
$536K Sell
7,445
-17
-0.2% -$1.28K 0.1% 105
2022
Q3
$530K Sell
7,462
-843
-10% -$61.2K 0.1% 100
2022
Q2
$644K Buy
8,305
+955
+13% +$72.7K 0.12% 88
2022
Q1
$541K Buy
7,350
+130
+2% +$8.73K 0.23% 75
2021
Q4
$450K Buy
+7,220
New +$424K 0.19% 98

Other funds holding BMY

Guardian Wealth Advisors (North Carolina)'s BMY Position: Q1 2026 in Review

Guardian Wealth Advisors (North Carolina) reduced its Bristol-Myers Squibb (BMY) stake by 5.5% in Q1 2026, selling an estimated $15.6K and leaving 4,589 shares worth $278K. The position accounts for 0.02% of the portfolio, ranked #293.

Guardian Wealth Advisors (North Carolina) first reported a position in BMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $644K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Guardian Wealth Advisors (North Carolina) held 4,589 shares of Bristol-Myers Squibb worth $278K as of Q1 2026.
  • Guardian Wealth Advisors (North Carolina) sold 268 Bristol-Myers Squibb shares in Q1 2026, an estimated $15.6K.
  • Bristol-Myers Squibb made up 0.02% of Guardian Wealth Advisors (North Carolina)'s portfolio in Q1 2026, its #293 holding.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 17 quarters since.
  • Guardian Wealth Advisors (North Carolina)'s Bristol-Myers Squibb position peaked at $644K in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 15 May 2026.